2019 | P001 | P001 -Challenges and successes of recruiting to a large cohort study - a research team's experience | Kelly White |
2019 | P002 | P002 -Telephone Clinics As An Adjunct To Face-to-Face Consultations in Geographically Remote Regions of The West of Scotland. | Oshorenua Aiyegbusi |
2019 | P003 | P003 -Does presumed care mean missed care? Establishing a new clinic service for patients with PTDM | Amy Riddell |
2019 | P004 | P004 -Improving Patient Access to Diabetic Services on Unit Haemodialysis – A Pilot Study | Aled Williams |
2019 | P005 | P005 -Renal peer support: initial insights and findings from developing, delivering and evaluating a two year pilot service | Hope Clayton |
2019 | P006 | Prevalence of physical and cognitive frailty in the low clearance population | Ambika Nedungadi |
2019 | P007 | P007 -Variation in practice for administering iodinated contrast agents to CKD4-5 patients in the low clearance clinics in the UK: a benchmarking exercise. | Michael Delaney |
2019 | P008 | P008 -Superior performance status in haemodialysis inpatients does not always translate into a shorter length of stay. | Sebastian Tullie |
2019 | P009 | P009 -Adverse effects of oral glucocorticoid therapy in autoimmune disease – a quality improvement project | Maria Prasinou |
2019 | P010 | P010 -Service development of kidney patient focussed counselling: 26 years of experience in a tertiary renal unit | Wigdan Hamza |
2019 | P011 | P011 -Exploring the experiences and concerns of staff and patients on an in-centre nocturnal haemodialysis programme | Katherine Hull |
2019 | P012 | P012 -The London Membranous Network | Sanjana Gupta |
2019 | P013 | P013 -Quality Improvement Project: Implementing New ‘ANCA sample’ pathway | Yosra Dafalla |
2019 | P014 | P014 -Outcomes of Multi-disciplinary Renal Emergency Simulations: Improved Participant Confidence in Communication and Team-working | David Rees |
2019 | P015 | P015 -Dietitian supplementary prescribing – experience of prescribing phosphate binders and alfacalcidol for haemodialysis patients | Elizabeth Rai |
2019 | P016 | P016 -“Handing over the prescription pad.” - Dietetic supplementary prescribing results in timely prescriptions for CKD-MBD medications and aims to improve patient experience in a cohort of dialysis patients. | Liz Brice |
2019 | P017 | P017 -Embedding a culture of shared haemodialysis care to increase the prevalence of sharing HD care with patients. | Jyoti Baharani |
2019 | P018 | P018 -"Traffic Light" Water Jug Lids: A Hydration Quality Improvement Project in Older Patients | Neil Hoye |
2019 | P019 | P019 -Share HD: the Birmingham experience | Miriam Berry |
2019 | P020 | P020 -Are we doing enough? An audit exploring the management of adults with diabetes on a hospital-based haemodialysis unit | Abigail Green |
2019 | P021 | P021 -Lister Renal Department Review of Renal Intravenous Chemotherapy Service | Jocelyn Berdeprado |
2019 | P022 | P022 -A retrospective review of the management of patients with a failing kidney transplant. | Lubna Rashid |
2019 | P023 | P023 -Delivering renal clinics differently: A cost and time efficient model for renal clinics with enhanced patient experience and peer support. | Emma Montgomery |
2019 | P024 | P024 -Native Renal Biopsy Complications within a Renal & Transplant Unit | Richard Greenhow |
2019 | P025 | P025 -Improving outcomes for haemodialysis new starters through implementation of an early review pathway – a trainee led quality improvement project | Javeria Peracha |
2019 | P026 | P026 -A JOY IN WORK APPROACH TO SERVICE CHANGE AND STANDARDISATION | Manasi Desai |
2019 | P027 | P027 -Exploring Patient Safety Among Renal Trainees | Ian Logan |
2019 | P028 | P028 -How to reach more patients with limited resources: a novel approach to delivering dietetic care to the low-clearance population. | Sophi Buddo |
2019 | P029 | P029 -Dialysis remote monitoring as an aid to telemedicine clinic: a single centre experience | Sivakumar Sridharan |
2019 | P030 | P030-Introduction of a lower cost branded calcineurin inhibitor for maintenance immunosuppression in kidney transplant recipients at a large UK transplant centre | Saehara Khan |
2019 | P031 | P031 -Impact of a multi-professional clinic designed to deliver personalised care to all patients who have recently started haemodialysis. | Emma Montgomery |
2019 | P033 | P033 -Association analysis of SNPs on Chromosome Y in renal disease in two cohorts. | Kerry Anderson |
2019 | P034 | P034 -Gene polymorphisms associated with microalbuminuria in 396,812 individuals from the UK Biobank cohort | Marisa Canadas Garre |
2019 | P035 | P035 -Analysis of risk variants through whole exome sequencing in steroid resistant nephrotic syndrome from a UK cohort | Caroline Platt |
2019 | P036 | P036 -Interpretation of rare heterozygous variants in recessive genes in a UK cohort of children with steroid resistant nephrotic syndrome | Caroline Platt |
2019 | P037 | P037 -Large scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative glomerulonephritis and C3 glomerulopathy | Daniel Gale |
2019 | P039 | P039 -Assessment of Microalbuminuria and its Clinical and Biochemical Correlates in Individuals with Sickle Cell Gene. | Ayoola Odeyemi |
2019 | P040 | P040 -Use of a gene panel for a diagnosis of cystic kidney disease and ciliopathy syndromes in an Omani population | John Sayer |
2019 | P041 | P041 -Adult presentation of Gitelman syndrome – don’t ignore persistent hypokalemia | Stephanie Urwin |
2019 | P042 | P042 -Prescribing tolvaptan for autosomal dominant polycystic kidney disease within the general nephrology clinic setting | Mohammed Al-Talib |
2019 | P043 | P043- Management of Gitelman syndrome in pregnancy: information resource for patients | Rupa Kumar |
2019 | P044 | P044 -X-linked Alport syndrome in the genomic medicine era - uncovering unusual clinical phenotypes of COL4A5 variants | Abhijit Dixit |
2019 | P045 | P045 -Efficacy and side-effects of tolvaptan in autosomal dominant polycystic kidney disease (ADPKD) - a single centre experience | Bryony Sedgwick |
2019 | P046 | P046 -2 years' experience of a pharmacist lead tolvaptan clinic | Claire Oates |
2019 | P047 | P047 -Developing a multi-disciplinary regional Tuberous Sclerosis clinic: the Liverpool Experience | Asheesh Sharma |
2019 | P048 | P048 -A large family kindred with CFHR5 Nephropathy | Patrick Walsh |
2019 | P049 | P049 -Clinical and genetic characteristics of autosomal dominant tubulointerstitial kidney disease – a case series | Abhijit Dixit |
2019 | P050 | P050 -The ADPKD Rare Diseases Group-2019 Update | Richard Sandford |
2019 | P051 | P051 -Arterial Stiffness is a Predictor for Acute Kidney Injury following Coronary Artery Bypass Graft Surgery | Sharlene Greenwood |
2019 | P052 | P052 -Predicting risk of recurrent acute kidney injury: a systematic review | Hilda Hounkpatin |
2019 | P053 | P053 -Improving the recognition and management of Acute Kidney Injury in a large teaching hospital: A Unique Nurse Led Service. | Rachel Fradley |
2019 | P054 | P054 -COMPLIANCE OF ACUTE KIDNEY INJURY (AKI) BUNDLE IN PATIENTS ADMITTED WITH AKI STAGE 3 | Arun Varadaraju Gopu |
2019 | P055 | P055 -Expanding and exploring AKI data submitted to the renal registry to gain better insight into patient cohorts of inpatients at an large acute hospital. | Becky Bonfield |
2019 | P056 | P056 -A qualitative study to explore nurses’ understanding of and attitudes to Acute Kidney Injury (AKI) and its management | Christina Armitage |
2019 | P057 | P057 -An audit of the care provided to patients with Acute Kidney Injury (AKI) at a teaching hospital trust in the UK | Christina Armitage |
2019 | P058 | P058 -Admission diagnosis as predictor of severity and one-year mortality in patients with acute kidney injury – a clinical audit. | Susil Pallikadavath |
2019 | P059 | P059 -IMPACT OF BODY MASS INDEX ON RENAL AND MORTALITY OUTCOMES AFTER ACUTE KIDNEY INJURY: A SYSTEMATIC LITERATURE REVIEW | Rochelle Blacklock |
2019 | P060 | P060-Impact of acute kidney injury electronic alerts and use of ‘sick day rules’ on patient outcomes: an observational cohort study. | David Baird |
2019 | P061 | P061 -Causes and co-morbidities for e-alerts for acute kidney injury in pregnancy | Rouvick Gama |
2019 | P062 | P062 -Recognition of pregnancy-related acute kidney injury with electronic alerts | Rouvick Gama |
2019 | P063 | P063 -Weight-based Assessment of Fluid Overload in Patients with Acute Kidney Injury | Bing Lun Chow |
2019 | P064 | P064 -Can small rises in serum creatinine in hospitalised patients predict outcomes? | Bnar Talabani |
2019 | P065 | P065 -Impact on urine output monitoring of its removal as a trigger from a track and trigger system | Esteban Prieto |
2019 | P066 | P066 -Chronic kidney disease in patients who have received renal support on ICU | Naomi Edney |
2019 | P067 | P067 -Acute Kidney Injury in Primary Care- 12 month observational study | Steve Dickinson |
2019 | P068 | P068 -The longer-term prognosis in Acute Kidney Injury (AKI) and the role of neoplasia. | Mark Thomas |
2019 | P069 | P069 -Prescribing pattern on the use of Statins following Acute Kidney Injury (AKI) | Aleli Akani |
2019 | P070 | P070 -Exploring the Feasibility of Urinary Biomarker Measurement (Nephrocheck®) to Stratify AKI Stage 1 in Medical Assessment Units | Memoona Jawed |
2019 | P071 | P071 -Dialysis dependent Acute Kidney Injury (DD-AKI) – developing a Regional collaborative study | Javeria Peracha |
2019 | P072 | P072 -Does baseline kidney function have an impact on outcomes of patients requiring renal replacement therapy on ITU? | Benjamin Perren |
2019 | P073 | P073 -Intervention at multiple stages in patient pathways lead to significant improvement in clinical outcomes in Acute Kidney Injury (AKI) | Shalabh Srivastava |
2019 | P074 | P074 -The Effect of Different definition of CKD progression on epidemiology of post AKI patients in a Large Prospective Parallel case control study of AKI | Isma Kazmi |
2019 | P075 | P075 -Five years on: The impact of introduction of electronic acute kidney injury alert (e-alert) and management pathway on patient care | Adil Hazara |
2019 | P076 | What do junior doctors know about Acute Kidney Injury? An educational audit and validation of an educational assessment tool. | Matthew Morgan |
2019 | P077 | P077 -ASSESSING SYMPTOM ASSESSMENT AND MANAGEMENT PROCESSES FOLLOWING THE ADMINISTRATION OF A PATIENT-REPORTED OUTCOME MEASURE TO HEMODIALYSIS PATIENTS IN ONTARIO | Rebecca Lum |
2019 | P078 | P078 -IMPLEMENTING A PATIENT-REPORTED OUTCOME MEASURE FOR HEMODIALYSIS PATIENTS IN ROUTINE CLINICAL CARE: PERSPECTIVES OF PATIENTS AND CLINICIANS | Rebecca Lum |
2019 | P079 | P079 -Changes at the UK Renal Registry: new annual report, new data access application process and new research ready dataset | Katharine Evans |
2019 | P080 | P080 -The impact of prevalent stroke at critical junctures in the pathway of care for patients with kidney disease | James Tollitt |
2019 | P081 | P081 -Comprehensive CKD Detection and coordination with Primary Care leads to reduction in late presentation for dialysis. | Johann Nicholas |
2019 | P082 | P082 -A detailed characterisation of cognitive impairment in patients with non-dialysis CKD | James Tollitt |
2019 | P083 | P083 -Elucidating the relationship between renal inflammation and metabolism in chronic kidney disease in the mouse through integrative computational modeling | Azadeh Harzandi |
2019 | P084 | P084 -Distribution and impact of urological malignancies on renal progression and mortality in advanced chronic kidney disease | Rajkumar Chinnadurai |
2019 | P085 | P085 -Cancer history is associated with mortality but not with renal progression in Non-Dialysis Chronic Kidney Disease | Rajkumar Chinnadurai |
2019 | P086 | P086 -Changing protein permeability with nephron loss; evidence for a human remnant nephron effect. | Jamie Willows |
2019 | P087 | P087 -The Prepare for Kidney Care Randomised Controlled Trial: Background, Intervention, Outcome Measures and Progress | Fergus Caskey |
2019 | P088 | P088- Development & Validation of a Multi-state Clinical Prediction Model in Chronic Kidney Disease and Renal Replacement Therapy | Michael Barrowman |
2019 | P089 | P089 -Development of a self-management behaviour scale for people on haemodialysis (HD) | Helen Munro Wild |
2019 | P090 | P090 -Improving the prescribing of statins in people with chronic kidney disease. | Sue Shaw |
2019 | P091 | P091 -Renal clinic – who is discharged and what are the outcomes | Rhodri Pyart |
2019 | P092 | P092 -Sustaining Quality Improvement – what does the ASSIST-CKD project tell us? | Nicola Thomas |
2019 | P093 | P093 -Evaluation of a Community Kidney Service education programme | Nicola Thomas |
2019 | P094 | P094 -Development of an electronic patient-reported outcome measurement system for routine symptom monitoring and management in patients with advanced chronic kidney disease: The RePROM Study. | Derek, K Kyte |
2019 | P095 | P095 -Urinary alpha 1 acid glycoprotein and progression to end stage renal disease in chronic kidney disease: a prospective observational cohort study. | Paul Cockwell |
2019 | P096 | P096 -Opportunities to improve care through optimising use of ACEi and ARB in high risk chronic kidney disease | Athif Hussain |
2019 | P097 | P097 -Audit of statin use in a chronic kidney disease population | Tariq Aljemmali |
2019 | P098 | P098 -Making the impossible possible: overcoming challenges to delivering a randomised controlled trial comparing ‘Preparation for Renal Dialysis’ with ‘Preparation for Responsive Management’ in older, co-morbid patients | Leila Rooshenas |
2019 | P100 | P100 -Most frequently reported barriers and benefits to exercise in peritoneal dialysis patients | Courtney Lightfoot |
2019 | P101 | P101 -Using initiatives to facilitate recruitment to exercise studies for patients with chronic kidney disease | Jennifer Barsana |
2019 | P102 | P102 -Cultural influences on physical activity and exercise beliefs in patients with Chronic Kidney Disease. | Juliet Mayes |
2019 | P103 | P103 -The impact of weekly group activities on an acute renal in-patient ward: Ending Pyjama Paralysis | Chris Gillespie |
2019 | P104 | P104 -What can help people with chronic kidney disease (CKD) be more active? | Heather Mackinnon |
2019 | P105 | P105 -The effects of high intensity interval training on cardiovascular structure and function in renal transplant patients. The C-PACE-KD study | Matthew Graham-Brown |
2019 | P106 | P106 -THE RELATIVE IMPORTANCE OF PHYSICAL FRAILTY AND CARDIOVASCULAR FUNCTION AS MODIFIABLE PREDICTORS OF FALLS IN HAEMODIALYSIS PATIENTS: A PROSPECTIVE COHORT STUDY | Tobia Zanotto |
2019 | P107 | P107 -Frailty, physical function, static balance and falls in CKD-5 patients on Heamodialysis | Pelagia Koufaki |
2019 | P108 | P108 -The acute physiological response to constant load exercise in end stage renal disease | Scott McGuire |
2019 | P109 | P109 -Lighting a SPArK: Feasibility testing of a theory-driven intervention to increase physical activity (PA) in non-dialysis chronic kidney disease. | Heather Mackinnon |
2019 | P110 | P110 -The sedentary practices of renal patients – an observational study of behaviour on an acute renal ward. | Susie McManus |
2019 | P111 | P111 -Identification of symptom clusters using the Kidney Symptom Questionnaire in patients with CKD stages 3b-5 not on dialysis | Thomas Wilkinson |
2019 | P112 | Symptom-burden and health-related quality of life in patients living with frailty and chronic kidney disease | Andrew Nixon |
2019 | P113 | P113 -The impact of acceptance of illness on quality of life outcomes for haemodialysis patients. | Carol Stalker |
2019 | P114 | P441 -The use of Patient-Reported Outcomes in patients with End Stage Renal Disease requiring treatment with Haemodialysis: a narrative review. | Nicola Anderson |
2019 | P115 | P115 -Designing a Wellbeing Month for Renal Patients | Margaret Eyre |
2019 | P116 | P116 -Developing a patient survey to evaluate patient reported experience and facilitate service improvement in aHUS. | Joanne Stout |
2019 | P117 | P117 -The experience of Chronic Kidney Disease patients: The results of the 2017 and 2018 Renal Association / Kidney Care UK Patient Reported Experience Measure | Catherine Stannard |
2019 | P118 | P118 -Impact of extended haemodialysis using the Theranova dialyser on patient reported outcome measures (PROMs). | Stephanie Bolton |
2019 | P119 | P119 -Empowering and Supporting Self Management | Rachel Gair |
2019 | P120 | “What else can you tell us about your experience of kidney care?” A qualitative analysis of patient comments from a free text box trialled in the 2018 Kidney PREM. | Janine Hawkins |
2019 | P121 | P121- IMPACT OF THE IMPLEMENTATION OF AN ASSISTED PERITONEAL DIALYSIS SERVICE ON PERITONEAL DIALYSIS INITIATION | Annabel Boyer |
2019 | P122 | Care experience with the 2% Chlorhexidine-infection at the exit site of the peritoneal dialysis patients | Wanshan Chiang |
2019 | P123 | P123 -Increasing The Prevalent Peritoneal Dialysis Patient Population Can Be Challenging. | Hari Dukka |
2019 | P124 | P124 -Case Report of the use of IP Daptomycin to treat VRE PD Peritonitis in a patient on APD | Bairavi Indrakumar |
2019 | P125 | P125 -The effect of glucose absorption on changes in body composition in peritoneal dialysis patients | Steven Law |
2019 | P126 | P126 -Travel and Peritoneal Dialysis: a safe combination | Derick Manthiri |
2019 | P127 | P127 -Measuring postural blood pressure to reduce the risk of falls in patients receiving peritoneal dialysis | Jennifer Allen |
2019 | P128 | P128-Buried peritoneal dialysis catheters: A single centre experience | Jennifer Allen |
2019 | P129 | P129 -A risk score tool to improve recognition and management of peritoneal dialysis patients at risk of peritonitis | Jennifer Allen |
2019 | P130 | P130 -Single centre outcome of PD related peritonitis in the UK | Jyoti Baharani |
2019 | P131 | P131 - Assessment of compliance with PD planning at a tertiary referral renal unit | Olatokunbo Abiodun |
2019 | P132 | P132 -Continuous improvement is better than delayed perfection -Exploring time on therapy: taking quality improvement in PD a step further | Jyoti Baharani |
2019 | P133 | P133 -Impact of remote patient management and monitoring system to support patients on automated peritoneal dialysis: One year on from implementation | Asra Karim |
2019 | P134 | P134 -Does peritoneal dialysis vintage affect relative leucocyte telomere length; a novel biomarker of ageing and mortality? | Vasantha Muthuppalaniappan |
2019 | P135 | P135 -Outcome measures for technique failure reported in peritoneal dialysis: a methodological systematic review | Emma Elphick |
2019 | P136 | P136 -Lupus Nephritis presenting as Tuberculosis Infection: a Case Report | MUHAMMAD TASSADUQ KHAN |
2019 | P137 | P137 -Organisation of a Mock OSCE in a renal dialysis unit to give final year students experience of examining patients with signs in a structured environment. | Pratik Solanki |
2019 | P138 | P138 -Management of Severe Hyperkalaemia in adults. | Nang Thin Zar Aye |
2019 | P139 | P139 -The four horsemen of the health care IT apocalypse? A heckle from the audience. | Eric Will |
2019 | P139 | P139 -‘Doing what comes easily’ in Clinical Science? | Eric Will |
2019 | P139 | P139 -Clinical Registries – a meme? | Eric Will |
2019 | P140 | P140 -Making an old emergency new again - Simulation in response to the national hyperkalaemia patient safety alert. | Rosa Montero |
2019 | P141 | P141 -Diagnostic Pathway in Patients Presenting with Acute Kidney Injury Secondary to de novo Multiple Myeloma: A Two Centre Experience | Ritika Rana |
2019 | P142 | P142 -Continuing To Take Time to Remember; Learning from an annual memorial service for renal patients, 2010-2018 and beyond | Eleanor King |
2019 | P143 | P143 -Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a scoping review | Hilda Hounkpatin |
2019 | P146 | P146 -Multi-morbidity patterns in patients with non-dialysis chronic kidney disease across England: a multi-centre cluster analysis | Thomas Wilkinson |
2019 | P147 | P147 -Use of a comprehensive electronic health record database to identify and describe clinical associations with hyperkalaemia, the treatments instituted and associated clinical outcomes | Toby Humphrey |
2019 | P148 | P148 -Insulin Use For The Treatment Of Acute Hyperkalaemia | Toby Humphrey |
2019 | P149 | P149 -Acute Treatment of Hyperkalaemia with Intravenous Insulin – Comparative Evaluation of Patient Characteristics | Toby Humphrey |
2019 | P150 | P150 -Feasibility of evaluation of the natural history of kidney disease using primary care electronic healthcare records | Faye Cleary |
2019 | P151 | P151 -Association of cancer history with mortality in end-stage renal disease patients on dialysis | Rajkumar Chinnadurai |
2019 | P152 | P152 -DIFFERENCES IN SYMPTOM BURDEN AND THE IMPACT ON PHYSICAL FUNCTION ACROSS PRIMARY AND SECONDARY CARE CKD POPULATIONS | Abina Dharmaratnam |
2019 | P153 | P153 -Home Haemodialysis (HHD) with low dialysate volume (LDV) – The Green benefit | Sunita Nair |
2019 | P154 | P154 -The incidence of neurocognitive disorders in the BETSI-COG-CKD study; initial findings from this longitudinal investigation. | Peter Hobson |
2019 | P155 | P155 -An association of body mass index and kidney function among 13-year-old Malaysian adolescents | Fathhullah Azmie Nawawi |
2019 | P156 | P156 -Is there an association between heat exposure and decreased kidney function? A systematic review | Ida Karlsson |
2019 | P157 | P157 -Hepatitis B vaccination as a cause of misdiagnosis of hepatitis B infection in haemodialysis patients: recommendations for avoiding diagnostic confusion. | April Wilson |
2019 | P158 | P158 -Population prevalence of impaired renal function in Uganda, Malawi and South Africa: baseline results of the ARK study | Laurie Tomlinson |
2019 | P159 | P159-How to estimate Glomerular Filtration Rate in sub-Saharan Africa: design and methods of the African Research on Kidney Diseases (ARK) study | Josie Prynn |
2019 | P160 | P160 -Protective effect of 1,25-dihydroxyvitamin D3 against contrast-induced nephropathy in diabetic rats through modulation of inflammatory responses, oxidative stress. | Li Xiangling |
2019 | P161 | P161 -RAPID APPEARANCE OF MEMBRANE-FREE, INTRACYTOPLASMIC INCLUSIONS IN THE RENAL PROXIMAL TUBULE EPITHELIAL CELL AFTER ISCHEMIA-REPERFUSION: A PATHOLOGICAL INVESTIGATION IN A PORCINE MODEL | David Gardner |
2019 | P162 | P162 -ABT-263 administration depletes radiation induced senescent cells and reduces renal fibrosis after subsequent injury | Katie Mylonas |
2019 | P163 | P163 -The role of SIRT5 in acute kidney injury | Timo Haschler |
2019 | P164 | P164 -Murine models of renal ischaemia reperfusion injury: An opportunity for refinement using non-invasive monitoring methods | Bettina Wilm |
2019 | P165 | P165 -Ankyrin Repeat and Single KH domain 1 (ANKHD1) is a novel driver of polycystic kidney disease in vivo. | Maria Fragiadaki |
2019 | P166 | P166 -Growth hormone inhibition in Autosomal Dominant Polycystic Kidney Disease | Fiona Macleod |
2019 | P167 | P167 -JAK2 inhibition halts the growth of polycystic kidney disease-derived epithelial cysts in vitro. | Maria Fragiadaki |
2019 | P168 | P168 -Vascular endothelial growth factor-C (VEGF-C) reduces cystogenesis in a human cellular model of polycystic kidney disease generated by CRISPR technology | Nuria Perretta Tejedor |
2019 | P169 | P169 -Vascular access in a district general hospital kidney unit: An 18 year experience | Emma Vaux |
2019 | P170 | P170-Vascular Access for Haemodialysis in Pregnancy – clinical practice and outcomes | Hannah Blakey |
2019 | P171 | P171 -A Systematic Review of Randomised Control Trials Comparing Cannulation Techniques for Arteriovenous Access for Haemodialysis | Catherine Fielding |
2019 | P172 | P172 -Haemodialysis Access Referral Form: A Systematic Approach in Referring Patients with Access Problem | Heidi Jimenez |
2019 | P173 | P173 -Thrombolytic use in tunnelled haemodialysis catheters post implementation of Citra-Lock™ S catheter locking solution. | Lisa Snelling |
2019 | P174 | P174 -Arteriovenous fistulas aneurysms in a UK dialysis population | Melanie Field |
2019 | P175 | P175-Patency of tunnelled central venous catheters for haemodialysis access: a systematic review | Hannah Blakey |
2019 | P176 | P176 -“I’ve been diagnosed since 1970 and nobody has ever given me advice on diet or lifestyle”: A research priority setting workshop with CKD patients treated in primary care | Thomas Wilkinson |
2019 | P177 | P177 -Greater knowledge of the health benefits of exercise is associated with higher physical activity levels in haemodialysis and peritoneal dialysis patients | Jared Palmer |
2019 | P178 | P178 -A Review of Anxiety and Depression amongst Haemodialysis Patients in the Western Trust | Andrew Walker |
2019 | P179 | P179 -Measuring shared decision making in routine clinical practice: Pilot of SDM-Q-9/-Doc and CollaboRATE scales within a low-clearance renal clinic. | George Russam |
2019 | P180 | P180 -Involvement of young people in a qualitative study that seeks to explore experiences of renal replacement therapy choice selection | Sarah Ofori-Ansah |
2019 | P181 | P181 -Identifying information needs of patients with IgA nephropathy: an innovative social media approach | Cristina Vasilica |
2019 | P182 | P182-What sources of information do patients report being most important in decision making? Results from a multicentre questionnaire-based study | Pippa Bailey |
2019 | P183 | P183 -ShareHD: Integrating co-production into standard unit practice | Samantha Jennings |
2019 | P184 | P184 -Patient focus group in addressing Immunosuppression related medication errors in a renal transplant centre | Pratik Solanki |
2019 | P185 | P185 -Cultural acceptance of Type 2 Diabetes and Hypertension within Black, Asian and Minority Ethnic groups may hinder the awareness of chronic kidney disease in some UK communities – an opportunity to increase engagement. | Gang Xu |
2019 | P186 | P186 -Analysis of missed outpatient clinic appointments at a District General Hospital based Renal Service | Jo Taylor |
2019 | P187 | P187 -‘Smarts’ a Virtual kidney assistant: Delivering high quality sustainable healthcare by empowering patients and healthcare teams. Co-produced with patients and healthcare professionals | Arvind Nagra |
2019 | P188 | P188 -‘PEEER’project- building Patient Empowerment, self Esteem, Employability and Resilience. A cost effective project: | Arvind Nagra |
2019 | P189 | P189 -Preemptive Therapy versus Universal Prophylaxis with Valganciclovir in minimizing the Risk of Cytomegalovirus Disease in Kidney Transplant Recipients | MUHAMMAD TASSADUQ KHAN |
2019 | P190 | P190 -Frequency of Urinary Tract Infection by Multidrug Resistance Organisms and its Effect on Graft Function in Renal Transplant Recipients | MUHAMMAD TASSADUQ KHAN |
2019 | P191 | P191 -Wound complications in early post-transplant period are associated with higher body mass index and poorer transplant outcome | Iain Moore |
2019 | P192 | P192 -RELATIONSHIP BETWEEN AORTIC DISTENSIBILITY, CORONARY ARTERY CALCIFICATION AND LEFT VENTRICULAR MASS IN RENAL TRANSPLANT RECIPIENTS: ASSESSMENTS FROM A CLINICAL TRIAL | Jennifer S Lees |
2019 | P193 | P193 -Cardiovascular disease and malignancy are the pre-eminent factors in transplant recipient mortality over a 5-year period | Iain Moore |
2019 | P194 | P194 -Endothelial Dysfunction and Blood Biomarkers in Kidney Transplant Patients | Joey Junarta |
2019 | P195 | P195 -The Exercise in Renal Transplant Online weight management (ExeRTiOn) study | Ellen Castle |
2019 | P196 | P196 -Differences exist in kidney graft survival among female recipients stratified by donor sex and recipient age: a population cohort analysis from the United Kingdom | Georgia Morgan |
2019 | P197 | P197 -Sex-dependent clinical outcomes after kidney transplantation: a retrospective single-centre analysis | Georgia Morgan |
2019 | P198 | P198 -Pre-transplant risk stratification for development of New Onset Diabetes After Transplantation (NODAT) in renal transplant recipients | Holly Mabillard |
2019 | P199 | P199 - Pre-operative factors predicting early admission to the intensive care unit (ICU) after kidney transplantation. | Nitin Abrol |
2019 | P200 | P200 -PRE-OPERATIVE LEFT VENTRICULAR DYSFUNCTION AND POST KIDNEY TRANSPLANT COMPLICATIONS: A SINGLE-CENTRE ANALYSIS | Zahrah Goolam-Mahomed |
2019 | P201 | P201 -PRE-OPERATIVE MYOCARDIAL PERFUSION SCANS AND POST KIDNEY TRANSPLANT COMPLICATIONS: A SINGLE-CENTRE ANALYSIS | Zahrah Goolam-Mahomed |
2019 | P202 | P202 -VALVULAR LESIONS FROM ROUTINE PRE-OPERATIVE ECHOCARDIOGRAMS AND POST KIDNEY TRANSPLANT COMPLICATIONS: A SINGLE-CENTRE ANALYSIS | Zahrah Goolam-Mahomed |
2019 | P203 | P203 -Participant experiences and satisfaction from the CAVIAR study | Kulli Kuningas |
2019 | P204 | P204 -Impact of Hypertension and White Coat Hypertension on Renal Function and Blood Pressure Post Kidney Donation | Aruni Ratnayake |
2019 | P205 | P205-Imaging challenges in transplant renal artery stenosis | David Baird |
2019 | P206 | P206 -A comparison between MDRD eGFR, creatinine clearance and kidney volume in renal transplant patients | Mustakim Khandaker |
2019 | P207 | P207 -What happens to diabetes medications after kidney transplants? | Rosa Montero |
2019 | P208 | P208 -Are we better at treating new onset diabetes after transplantation than type 2 diabetes mellitus in kidney transplant patients? | Rosa Montero |
2019 | P209 | P209 -Is blood sugar control better in type 1 diabetes mellitus or type 2 diabetes mellitus post renal transplant? | Rosa Montero |
2019 | P210 | P210 -Donor characteristics limit opportunities for black patients to receive renal transplantation | Jessica Kearney |
2019 | P211 | P211 -Sleep quality in renal transplant recipients: an analysis using the Pittsburgh Sleep Quality Index | Roseanne Billany |
2019 | P212 | P212 -Optimising outcomes for older patients: are adult children an underutilised ally in transplantation? | Conor Oliver |
2019 | P213 | P213 -Post-transplant DEXA scan results in correlation to incidence of fracture | Omar Ragy |
2019 | P214 | P214 -Cutaneous Malignancies in Renal Transplant Recipients - an analysis of 296 patients in “Sunny Cornwall” | Steve Dickinson |
2019 | P215 | P215 -The role of HLA mismatch and HLA-Cw7 in the development and clearance of polyoma virus following kidney transplantation | Jaya Patel |
2019 | P216 | P216 -A clinical, immunogenetic and immunophenotyping re-evaluation of the risk factors for and consequences of CMV disease following kidney transplantation, with a focus on cardiovascular sequelae | Jaya Patel |
2019 | P217 | P217 -The Use of Dual and Triple Immunosuppression Strategies For Kidney Transplant Recipients at a Single Centre. | Uwadiegwu Okoroafor |
2019 | P218 | P218 -Anaemia management in four renal transplant recipients secondary to Ribavirin therapy | Catherine Byrne |
2019 | P219 | P219 -Skin cancer awareness and compliance with photo protection in long-term kidney transplant patients: A single centre cohort analysis | Antonia Cronin |
2019 | P220 | P220 -Prevalence of cancer in long-term kidney transplant patients: A single centre retrospective analysis | Antonia Cronin |
2019 | P221 | P221 -Body weight based initial dosing of tacrolimus post renal transplant- Is this an ideal approach? | Rajkumar Chinnadurai |
2019 | P222 | P222 -IgM-dominant Glomerular Immune Complex Deposition in the Renal Allograft: a case series | Neeru Agarwal |
2019 | P223 | P223 -Does a review of non-attenders to transplant clinic followed by intervention, offer an opportunity to re-engage patients and identify factors that lead to non-attendance? | Joana Teles |
2019 | P224 | P224 -Understanding clinician attitudes towards the influence of pre-transplant non-adherence on patient eligibility for renal transplantation. | Abigail Hucker |
2019 | P225 | P225 -Obesity obsession! Are we missing out potential transplant candidates? | Nageen Anwar |
2019 | P226 | P226-When polycystic kidneys are problematic: what nephrologists need to know about nephrectomy outcomes | Aaron Lake |
2019 | P227 | P227 -Renal Transplantation in the Over 70s – Outcomes at A Single Centre. | Monica Bowa- Nkhoma |
2019 | P228 | P228 -MIBI or not MIBI? That is the question – cardiac considerations for potential kidney transplant recipients | Aditi Verma |
2019 | P229 | P229 -Is pre-renal transplant frailty and/or telomere length associated with length of stay and hospital readmissions post transplantation? | Vasantha Muthuppalaniappan |
2019 | P230 | P230 -Role of cinacalcet in post-transplant hyperparathyroidism | Ismaa Kiani |
2019 | P231 | P231 -Does size matter? Single central study looking at split function of live donor kidneys and their disparity in size. | Arvind Singh |
2019 | P232 | P232 -The development of multi-parameter flow cytometry panels to identify immune cells in renal transplant recipients and healthy controls | Ganisha Fatania |
2019 | P233 | P233 -Cardiovascular events in early chronic kidney disease and their association with markers of mineral bone disease | Maarten Taal |
2019 | P234 | P234 -The association between serum sodium concentration and albuminuria: a retrospective cohort study | Nicholas Cole |
2019 | P235 | P235 -Is there a rationale for biomarker stratified clinical trial for primary prevention of heart failure in chronic kidney disease? | Shanmugakumar Chinnappa |
2019 | P236 | P236 -Contraception practice amongst women with hypertension | Hannah Bradshaw |
2019 | P237 | P237 -PROGRESSION OF MYOCARADIAL FIBROSIS IN CKD | Manvir Kaur Hayer |
2019 | P238 | P238 -Interruption of antiplatelets / anticoagulants and the risk of major adverse cardiovascular events (MACE) among patients undergoing renal biopsy | Yosra Dafalla |
2019 | P239 | P239 -Clinical, Angiogenic and Immune System Markers Predict Pre-Eclampsia in Women with CKD During Pregnancy | Nadia Sarween |
2019 | P240 | P240-Progression and determinants of atherosclerosis and other vascular markers in patients with chronic kidney disease compared to healthy volunteers | Debasish Banerjee |
2019 | P241 | P241 -Recruitment and retention of participants to a pilot cluster randomised trial of an arts-based intervention for patients with end-stage kidney disease whilst receiving haemodialysis. | Claire Carswell |
2019 | P242 | P242 -Illness Perceptions In Renal Disease correlate with Wellbeing Markers | Zoe Pittman |
2019 | P243 | P243 -Exploring beliefs About Treatment in Advanced CKD and Relationship with Wellbeing and Outcome | Zoe Pittman |
2019 | P244 | P244 -The role of illness perceptions in designing psychological interventions for haemodialysis (HD) patients from South Asian backgrounds | Shivani Sharma |
2019 | P245 | P245 -Vascular calcification in advanced CKD and its relationship with bone microstructures | Syazrah Salam |
2019 | P246 | P246 -Setting targets for the management of mineral bone disorders in haemodialysis –do they help us? | Colin Jones |
2019 | P247 | P247 -Analysis of kidney stone composition in a contemporary, large, region wide cohort from the North East of England | John Sayer |
2019 | P248 | P248 -The SIMPLIFIED Registry Trial: Towards Delivery of Streamlined Dialysis Trials in the United Kingdom. | Thomas Hiemstra |
2019 | P249 | Cinacalcet Treatment for Secondary Hyperparathyroidism, Single Centre Experience. | Chera Arunachalam |
2019 | P250 | P250 -Design of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Examine the Efficacy and Safety of SNF472 for Treating Calcific Uremic Arteriolopathy (Calciphylaxis) | Stephan Miller |
2019 | P251 | P251 -Oral vs intravenous (IV) pulsed alfacalcidol for the treatment of secondary hyperparathyroidism (SHPT) in haemodialysis patients – an audit of efficacy and cost | Qiaoling Zhou |
2019 | P252 | P252 -REAL-WORLD EXPERIENCE OF THE SAFETY AND EFFECTIVENESS OF SUCROFERRIC OXYHYDROXIDE IN UK DIALYSIS PATIENTS: AN INTERIM SUBGROUP ANALYSIS OF THE VERIFIE STUDY | Kerry Gardiner |
2019 | P253 | P253 -Challenges accessing rehabilitation leads to increased length of stay for haemodialysis patients | Iain Moore |
2019 | P254 | P254 -Simulation Training: an under-utilised method of education for renal nurses? | Karen Jenkins |
2019 | P255 | P255 -Anticoagulation on haemodialysis: Switching from Tinzaparin to Dalteparin | Jennifer S Lees |
2019 | P256 | P256 -Does an individualised Treatment Plan Aimed at Improving the Management of Cardiac Instability on Haemodialysis improve Health and wellbeing? | Sharon Huggins |
2019 | P257 | P257 -The use of a Trigger Tool to detect harm during Haemodialysis: A prospective data review. | Jemima Self |
2019 | P258 | P258 -DEVELOPMENT OF AN IN VITRO SIMULATION MODEL TO INVESTIGATE HEMODYNAMIC RESPONSES DURING HAEMODIALYSIS | Venkata R Latha Gullapudi |
2019 | P259 | P259 -MEASURING PRESSURE WAVES IN DIALYSIS LINES TO DERIVE CONTINUOUS ARTERIAL BLOOD PRESSURE: PILOT WORK IN AN IN VITRO AND IN SILICO MODEL. | Venkata R Latha Gullapudi |
2019 | P260 | P260 -FREQUENCY ANALYSIS REVEALS UNIQUE HAEMODYNAMIC RESPONSES TO HAEMODIALYSIS: BASELINE RESULTS FROM THE ITREND STUDY | Venkata R Latha Gullapudi |
2019 | P261 | P261 -Absolute transcapillary plasma refilling rate and its variability during haemodialysis | Nicos Mitsides |
2019 | P262 | P262 -Medicines Optimisation in maintenance haemodialysis patients – Survey of UK renal units | Alison Westley |
2019 | P263 | P263 -Factors affecting the changes in dry weight among Hemodialysis patient population | Shoab Saadat |
2019 | P264 | P264 -Does a specific dialysis protocol in acute stroke patients affect morbidity and mortality: A four-year retrospective analysis. | Charles Hall |
2019 | P265 | P265 -Comparing haemodialysis protocols in neuro-trauma and acute stroke across London’s renal centres | Charles Hall |
2019 | P266 | P266 -Auditing the inter-dialytic weight gain of haemodialysis patients over a three year period from 2016 to 2018. | Yukie Omichi |
2019 | P267 | P267 -Acute Effects of Haemodialysis on Skeletal Muscle Perfusion, Metabolism and Function: A Systematic Review | Shatha Al Mushayt |
2019 | P268 | P268 -Maintenance haemodialysis patient knowledge and appetite for medicines education – single centre survey | Alison Westley |
2019 | P269 | P269 -Intradialytic cycling: putting the brakes on the rising costs of hospital resources | Adam Hurt |
2019 | P270 | P270 -What are the determinants of a late dialysis modality decision or decision change? A retrospective analysis | Alice Culliford |
2019 | P271 | P271 -What happens to patients who have unplanned dialysis starts due to late decision making or late decision changes after six months? | Alice Culliford |
2019 | P272 | P272 -Reducing our carbon footprint and resource use: A single centre experience of changing our practice to be more environmentally sustainable. A quality improvement project (QIP). | Hannah Jenkins |
2019 | P273 | P273 -Predicting change in dry weight of a Hemodialysis patient over the coming month using Xgboost Machine Learning algorithm | Shoab Saadat |
2019 | P274 | P274 -A novel personalised nurse-led pathway improves clinical outcomes and reduces costs for patients commencing haemodialysis: a single centre quality improvement pilot | Asheesh Sharma |
2019 | P275 | P275 -Acetate-free biofiltration: an underappreciated treatment option in managing haemodialysis patients. | Bethan England |
2019 | P276 | P276 -Patients’ attitude towards access for haemodialysis. | Jonny Varma |
2019 | P277 | P277 -Impact of patient educational level on the prevalence of complications amongst haemodialysis patients. | Jonny Varma |
2019 | P278 | Paclitaxel assisted balloon Angioplasty of Venous stenosis in haEmodialysis access (PAVE); Study Protocol for the double-blind, multi-centre, randomised controlled trial to evaluate the efficacy of additional paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis | Michael Robson |
2019 | P279 | P279 -Using Data to Drive Quality Improvement: The Haemodialysis Patient Safety Index One Year On | Catherine Fielding |
2019 | P280 | P280 - Pericardial effusions in patients with renal disease: a single centre experience | Amarpreet Thind |
2019 | P281 | P281 -Allergic reactions during haemodialysis treatment secondary to dialysis catheters | Kateryna Macconaill |
2019 | P282 | P282 -Clinical review of cause of death in adults undergoing in-center chronic haemodialysis between 2016 and 2018 | Mwayiwathu Prince Mtekateka |
2019 | P283 | P283 -Change in frequency of haemodialysis related cramps over the past decade :- is modern dialysis better tolerated? | Lisa Tang |
2019 | P284 | P284 -Impact of Short-Term Change from Haemodiafiltration to High-Flux Haemodialysis on Phosphate Control | Alice Culliford |
2019 | P285 | P285 -Personalised dialysate flow reduces cost without reduction in dialysis quality | Stephen John |
2019 | P286 | P458 -Evaluating symptom prevalence and management for patients on haemodialysis. | Patrick Mcaleavey |
2019 | P287 | P287 -Impact of major vascular intervention for peripheral vascular disease among diabetic patients on Haemodialysis – A retrospective study | Sivaramakrishnan Ramanarayanan |
2019 | P288 | P288 -Our experiences working with the implementation of new eligibility criteria for patient transport for renal patients. Practical reflections on what we have learnt and suggestions for colleagues. | Eleanor King |
2019 | P289 | P289 -The association between salt intake scored by Scored Salt Questionnaire and markers of fluid overload in haemodialysis patients | Manasi Desai |
2019 | P290 | P290 - HOSPITALISATION RATES WITHIN ONE YEAR OF COMMENCEMENT OF RENAL REPLACEMENT THERAPY- SINGLE CENTRE EXPERIENCE | Venkata R Latha Gullapudi |
2019 | P291 | P291 -Use of a Portable Dialysis Machine to facilitate treatment of dialysis-dependent patients on the Intensive Care Unit at University Hospital Southampton NHS Trust | Kirsty Armstrong |
2019 | P292 | P292 -‘I just don’t want to rock the boat’: uncovering barriers and facilitators to recruitment in the H4RT trial with an integrated QuinteT Recruitment Intervention. | Fergus Caskey |
2019 | P293 | P293-usage of renin-angiotensin aldosterone system (RAAS) blockade to reduce the cardiovascular risks in patients on regular haemodialysis - review of a practice in a single center dialysis unit | Jonathan Chevassut |
2019 | P294 | P294 -Burden in patients and their informal caregivers living with haemodialysis in Saudi Arabia: A cross sectional study. | Bushra Alshammari |
2019 | P295 | P295 -Development of nocturnal guidelines for home haemodialysis by special interest group for home haemodialysis nurses (SIGNhd-UK) | Laura Thompson |
2019 | P296 | P296 -The association of Diastolic Blood Pressure control with clinical outcomes in incident haemodialysis patients | Ryan Kelly |
2019 | P297 | P297 -Single central experience of femoral Tesio Catheters for Long term Haemodialysis use. | Arvind Singh |
2019 | P298 | P298 -Characterisation of Haemodynamics in Haemodialysis Patients with Chronic Kidney Disease using the non-invasive Ultrasonic Cardiac Output Monitor (USCOM): a prospective serial measurement, observational study | Dena Pitrola |
2019 | P299 | P299 -The role of a young adult transition nurse in a renal service | Victoria Carnall |
2019 | P300 | P300 -Evidencing the impact of a young adult service: specialist support results in a sustained decrease in clinic non-attendance over 8 years | Terri Ellwood |
2019 | P301 | P301 -Kidney disease is the commonest cause of secondary hypertension in young adults | James Savage |
2019 | P302 | P302-The national residential project for young adults with CKD. | Laura Baines |
2019 | P303 | Meeting the needs of Young Adults with Inflammatory Kidney Diseases – A Service Evaluation | Matthew Morgan |
2019 | P304 | P304 -Relapse of ANCA-associated vasculitis with recurrence of pyoderma gangrenosum and de novo pulmonary haemorrhage | Matthew Beresford |
2019 | P305 | P305 -Variable response to induction therapy and significant burden of treatment adverse events over the first 12 months of remission induction treatment in ANCA Associated Vasculitis (AAV) Patients – a study of routine clinical practice | Peter Rutherford |
2019 | P306 | P306 -Uptake of the pneumococcal and influenza vaccine in patients with ANCA-associated vasculitis | Ellen Kay |
2019 | P307 | P307 -Changes in Body Mass Index (BMI) in patients with ANCA Associated Vasculitis (AAV) following initiation of induction therapy: a single centre cohort study | Nina Brown |
2019 | P308 | P308 -Long term outcomes of patients with ANCA associated vasculitis presenting with severe renal dysfunction | Anisha Tanna |
2019 | P309 | P309 -THE LONGITUDINAL COURSE OF FATIGUE IN ANCA ASSOCIATED VASCULITIS | Dimitrious Chanouzas |
2019 | P310 | P310-Utility of a one-stop joint ENT-Vasculitis clinic in the management of relapsing ANCA-associated vasculitis | Dimitrious Chanouzas |
2019 | P311 | P311 -Risk stratification tools in ANCA-associated glomerulonephritis | Christopher Saleh |
2019 | P312 | P312 -Diffuse Alveolar Haemorrhage Secondary to Lung Biopsy Proven Anti-GBM Disease with Negative Circulating Anti-GBM Antibodies by Standard ELISA – Case Report – | Yasser Al-Mula Abed |
2019 | P313 | P313 -A quality improvement project on the management of serum phosphate levels in adult haemodialysis patients, focusing on patient education and intensive renal dietetic review | Jaimeet Jassal |
2019 | P314 | P314 -Factors associated with change in skin autofluorescence in dialysis patients: a prospective study. | Daniela Viramontes Horner |
2019 | P315 | P315 -Exploring the relationship between habitual dietary zinc intake, appetite, and total energy consumed in CKD | Eleanor Gore |
2019 | P316 | P316 -ASSOCIATION BETWEEN DIETARY COMPONENTS AND VASCULAR STIFFNESS: ASSESSMENTS FROM RENAL TRANSPLANT RECIPIENTS PARTICIPATING IN A CLINICAL TRIAL | Jennifer S Lees |
2019 | P317 | P317 -How handgrip strength changes over the course of a haemodialysis session. | Nicola Fernandez |
2019 | P318 | P318 -Investigating the fluid and salt knowledge of patients within an ethnically diverse haemodialysis population | Katie Durman |
2019 | P319 | P319 -Dietary factors associated with obesity in acute kidney injury: a cross-sectional study | Rochelle Blacklock |
2019 | P320 | P320 -Auditing the use of water-soluble vitamin supplementation in haemodialysis patients against European Renal Best Practice and Renal Association guidelines. | Leia Kenney |
2019 | P321 | P321 -The efficacy of oral probiotic, prebiotic and synbiotic supplementation in modulating gut derived circulatory toxic particles associated with mortality in dialysis patients: a systematic review and meta-analysis of randomised controlled trials | Daniel March |
2019 | P322 | P322 -Post-operative nutritional management of Simultaneous pancreas and kidney transplant patients- Current practices in UK and Ireland | Stella Kourtellidou |
2019 | P323 | P323 -Assessing the effectiveness of a modified X-PERT programme on dietary patterns in patients with diabetes and end stage renal disease (ESRD) | Sandra Tan |
2019 | P324 | P324 -Impact of dietetic intervention on skin autofluorescence and nutritional status in dialysis patients: a proof of principle study | Daniela Viramontes Horner |
2019 | P325 | P325 -An audit to compare the difference between actual nutritional intakes versus nutritional requirements of ward haemodialysis patients. | Zoe Ramsey |
2019 | P326 | P326 -An examination of the dietitian workload on the renal ward. | Joanna Finney |
2019 | P327 | P327 -An audit on nutritional screening practice in patients with Chronic kidney disease | Manasi Desai |
2019 | P328 | P328 -Exploring parent and adult-child experiences of support and decision making with polycystic kidney disease: A joint interview case study | Lucina Wilde |
2019 | P329 | P329 -Experience of genomics through 100,000 Genomes Project for paediatric renal rare disease patients at a specialised hospital. | Maria Kokocinska |
2019 | P330 | P330 -Eculizumab Safety: 5-Year Experience From the Global aHUS Registry | Rodney Gilbert |
2019 | P331 | P331 -Syndromic C3 glomerulopathy reveals a shared genetic risk factor with age-related macular degeneration | Gemma Thompson |
2019 | P332 | P332 -A Novel SGPL-1 gene mutation causing a congenital nephrotic syndrome with associated primary adrenal insufficiency | Dean Wallace |
2019 | P333 | P333 -Prevalence of co-morbidities and their impact on survival of conservatively managed patients with stage 5 chronic kidney disease | Kirsty Ward |
2019 | P334 | P334 -One size does not fit all - A regional networked approach to optimising care to frail and elderly renal patients in South London. | Kate Shepherd |
2019 | P335 | P335 -Single centre experience of Conservative Kidney Management (CKM) for End Stage Renal Disease (ESRD) in elderly patients. | Rishana Shuaib |
2019 | P336 | P336 -How Can Renal Specialist Nurses Recognise and Respond to Frailty in the Pre-Dialysis Clinic? | Andrew Mooney |
2019 | P337 | P337 -What is the Benefit of Having a Geriatrician in the Low Clearance Clinic? | Andrew Mooney |
2019 | P338 | P338 -THe East and NoRth LOndon DIabetes Cohort Study (HEROIC): Rationale, Study Design and Outline Protocol | Ben Caplin |
2019 | P339 | P339 -Diabetes in patients receiving renal replacement therapy – the challenges of using registry data | Rhodri Pyart |
2019 | P340 | P115- TRPC6 binding to and activation of calpain regulates podocyte motility | Louise Farmer |
2019 | P341 | P341 -The role of the G-actin sequestering peptide Thymosin Beta-4 in renal podocyte function | William Mason |
2019 | P342 | P342 -Post-translational regulation of endothelial derived CCN proteins in response to uremic serum from haemodialysis patients | Nihil Chitalia |
2019 | P343 | P343 -Uraemic sera-induced in-vitro calcification of human aortic smooth muscle cells involves regulation of Klotho and RUNX2 | Ken Farrington |
2019 | P345 | P345 -Know your PLCE: A Role for PLCε in Controlling the Podocyte’s Response to TGF-B1 | Carl May |
2019 | P346 | P346 -A proteomic roadmap comparing mechanisms of action of antifibrotics in an in-vitro model of TGF-β1-induced fibrogenesis in renal fibroblasts | Qihe Xu |
2019 | P347 | P347 -Proteomic landscape of an in-vitro model of TGF-β1-induced fibrogenesis in renal fibroblasts | Qihe Xu |
2019 | P348 | P348 -The role of GATA3 in bone morphogenetic protein 7 (BMP7) dependent prevention and reversal of myofibroblast phenotype | Irina Grigorieva |
2019 | P349 | P349 -Multiparametric Renal MRI to Assess Structure and Function in Chronic Kidney Disease | Rebecca Noble |
2019 | P350 | P350 -DETERMINING OPTIMAL TECHNIQUE FOR TISSUE FIXATION FOR EX-VIVO MRI IMAGING OF PORCINE KIDNEYS | Isma Kazmi |
2019 | P351 | P351 -Extracellular electrical resistance is inversely associated with tissue ionic sodium status and serum osmolality – implications for bioimpedance-derived hydration status in chronic kidney disease | Nicos Mitsides |
2019 | P352 | P352 -The utility of magnetic resonance native T1 mapping for renal tissue characterisation in patients with IgA Nephropathy | Matthew Graham-Brown |
2019 | P353 | P353 -Remote urine dipstick analysis for faster treatment of urinary tract infections using smartphone technology | Rachel Middleton |
2019 | P354 | P354 -Enhanced education leads to enhanced care | Anca Ichim |
2019 | P355 | P355 -Improving Patient Pathways Using Information Technology – PRESCHOOL learning tool | Christopher Swan |
2019 | P356 | P356 -Overcoming Isolation in Home Haemodialysis Patients | Christopher Swan |
2019 | P357 | P357- Short frequent haemodialysis at home does not appear to be associated with accelerated loss of residual renal function | Hannah Beckwith |
2019 | P358 | P358 -The Effect of Dialysis Modality Choice on Cognitive Functions in Patients with End Stage Renal Failure : A Systematic Review and Meta-analysis | Hatem Ali |
2019 | P359 | P359 -CAN CONTINUOUS QUALITY IMPROVEMENT TO MAINTAIN A PERITONEAL DIALYSIS PROGRAMME | Jyoti Baharani |
2019 | P360 | P360 -PATIENTS’ PERCEPTION OF AUTOMATED PERITONEAL DIALYSIS REMOTE MONITORING | Jyoti Baharani |
2019 | P361 | P361 -Sharing practices and standards to improve sustainability of home haemodialysis globally. SIGNhd Global. | Laura Thompson |
2019 | P362 | P362 -Home dialysis for profound deaf patient: a case study | Sarah Ofori-Ansah |
2019 | P363 | P363-Improving access to home haemodialysis for patients and education for in-centre Haemodialysis staff using a dialysis roadshow approach | Jyoti Baharani |
2019 | P364 | P364 -Assist-HHD Study: A feasibility study Into staff-assisted Home Hemodialysis (aHHD) as an alternative dialysis modality | Kunaal Kharbanda |
2019 | P365 | P365 -Virtual Home Haemodialysis Review Tool (VH2RT): A Framework For Managing a Large Home Haemodialysis Programme | Kunaal Kharbanda |
2019 | P366 | P366 -Tolvaptan, An innovative treatment or a disappointment for ADKPD patients? A single centre's experience. | Declan Keenan |
2019 | P367 | P367 -THE ACUTE USE OF VELTASSA (PATIROMER) IN A TERTIARY RENAL UNIT | Amin Oomatia |
2019 | P368 | P368-Investigation of the receptor mediated drug-creatinine interaction using trimethoprim in advanced chronic kidney disease- A pilot study | Rajkumar Chinnadurai |
2019 | P369 | P369 -Impact of chronic kidney disease on the drugs eliminated predominantly through a non-renal route: A proof of concept study with citalopram | Rajkumar Chinnadurai |
2019 | P370 | P370 -Is oral vitamin B12 and folate supplementation (Renavit®) adequate in patients on high-flux haemodialysis and haemodiafiltration ? | Clare Morlidge |
2019 | P371 | P371 -Does chronic kidney disease affect the non-renal elimination of calcineurin inhibitors? | Rajkumar Chinnadurai |
2019 | P372 | P372 -The effect of prophylactic Tinzaparin on anti-Xa levels in patients with Chronic Kidney Disease 3-5. | Seema Jham |
2019 | P373 | P373 -Prescribing Safety Indicators In Patients With Chronic Kidney Disease: A Systematic Review | Fiona Smith |
2019 | P374 | P374 -The effects of tolvaptan on liver and kidney function in patients with Autosomal Dominant Polycystic Kidney Disease | Matt Hall |
2019 | P375 | P375 -Cockroft-Gault vs CKD-EPI for estimating GFR when dosing aminoglycosides | Joanna Willis |
2019 | P376 | P376 -Clinical evaluation of biosimilar anti-CD20 monoclonal antibody with Rituximab in the treatment of ANCA-Associated Vasculitis | Anna Iacovou |
2019 | P377 | P377 -Mycophenolate mofetil in Lupus Nephritis – effective and safe over at least 10 years, a single centre experience. | Hannah Beckwith |
2019 | P378 | P378 -Fibrillary glomerulonephritis: A case series (a single centre experience) | Zay Htet |
2019 | P379 | P379 -Infective complications following Rituximab treatment – A single centre experience | Laura Gillis |
2019 | P380 | P380 -A case of post infectious glomerulonephrits secondary to streptcoccus parasanguinis endocarditis | Gemma Thompson |
2019 | P381 | P381 -Randomised Controlled Trial Protocol: The Use of Rituximab In the treatment of Nephrotic Glomerulonephritis (TURING) | Lisa Willcocks |
2019 | P382 | P382-Long term renal outcomes in patients with IgA vasculitis: A single-centre retrospective cohort study | Chee Kay Cheung |
2019 | P383 | P383 -Treatment of idiopathic membranous nephropathy using mycophenolate mofetil: a case series | Hannah Ariff |
2019 | P384 | P384 -Benefit or burden: a systematic review and meta-analysis of treatment outcomes of ANCA-associated vasculitis in patients over the age of 75 years | Adam Morris |
2019 | P385 | P385 -Using long term outcome data to redefine proteinuria and eGFR endpoints for lupus nephritis trials: proteinuria targets need not be so stringent | Hannah Wilson |
2019 | P386 | P386 -Comparison of treatment in a large cohort of lupus nephritis: Excellent long-term outcome with no difference in response or flare between oral steroid and steroid-free regimens | Hannah Wilson |
2019 | P387 | P387 -Single Centre Experience of Rituximab Use in Nephrotic Syndrome | Tharindra N Somasinghe |
2019 | P388 | P388 -Belimumab treatment offers a new steroid avoiding opportunity for non renal lupus activity in patients with lupus nephritis. | Sarah Gleeson |
2019 | P389 | Ovarian protection in patients receiving cyclophosphamide for lupus nephritis | Sarah Gleeson |
2019 | P390 | P390 -Self-limiting nephrotic syndrome, acute kidney injury, and red cell aplasia – a case report of parvovirus associated glomerulonephritis | Stephanie Urwin |
2019 | P391 | P391 -Long term outcomes of rituximab treatment in membranous nephropathy | Lina Nikolopoulou |
2019 | P392 | P392 -Outcomes of renal vasculitis over 20 years in a tertiary renal unit | Helena Edwards |
2019 | P393 | P393 -CARDIOVASCULAR DISEASE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS | Allyson Egan |
2019 | P394 | P394 -RENAL INVOLVEMENT IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS | Allyson Egan |
2019 | P395 | P395 -Relapse rate in systemic lupus erythematosus with or without lupus nephritis | Dimitrious Chanouzas |
2019 | P396 | P396 -A single centre retrospective review of acute kidney injury in neonates with congenital diaphragmatic hernia | Aoife Ryan |
2019 | P397 | P397 -Clinical Practice Guideline: Monitoring children and young people with, and at risk of developing Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Matko Marlais |
2019 | P398 | P398 - HNF1B mutations are associated with an evolving tubulopathy in childhood | Shazia Adalat |
2019 | P399 | P399 -Sarcoidosis-associated renal impairment – a single centre experience | Tariq Aljemmali |
2019 | P400 | P400 -CHARACTERISING FUMADERM-INDUCED FANCONI SYNDROME: A CASE SERIES | Elizabeth Wan |
2019 | P401 | P133 -Retrospective review of acute interstitial nephritis: a 12-year single centre experience | Mahzuz Karim |
2019 | P402 | P402 -The role of the calprotectin/ RAGE/ TLR4 axis in ANCA-Associated vasculitis | Theresa Page |
2019 | P403 | P403 -Complement in membranous nephropathy | Lina Nikolopoulou |
2019 | P404 | P404 -Acute kidney injury (AKI) | Nick Selby |
2019 | P405 | P405 -Anaemia | Sunil Bhandari |
2019 | P406 | P406 -Autosomal dominant polycystic kidney disease (ADPKD) | Tess Harris |
2019 | P407 | P407 -Cardio-renal | Paddy Mark |
2019 | P408 | P408 -Chronic kidney disease, progression and biomarkers | Maarten Taal |
2019 | P409 | P409 -Exercise and lifestyle | Sharlene Greenwood |
2019 | P410 | P410 -Glomerulonephritis (GN), lupus nephritis and vasculitis | Liz Lightstone |
2019 | P411 | P411 -Haemodialysis and vascular access | Sandip Mitra |
2019 | P412 | P412 -Chronic kidney disease mineral and bone disorder | Indranil Dasgupta |
2019 | P413 | P413 -Paediatric nephrology | Sally Johnson |
2019 | P414 | P414 -Peritoneal dialysis | Mark Lambie |
2019 | P415 | P415 -Transplantation | Sian Griffin |
2019 | P416 | P416 -UK Renal Imaging Network (UKRIN) | Susan Francis |
2019 | P417 | P417 -UK Renal Trials Network (UKRTN) | Thomas Hiemstra |
2019 | P418 | P418 -UK Renal Fibrosis Network (UKRFN) | Claire Sharpe |
2019 | P419 | P419 -UK Renal Regenerative Medicine Network (UKRRMN) | Bettina Wilm |
2019 | P420 | P420 -Changes in regulatory and Th2-like populations, but not “senescence” phenotype characterise lymphocytes in older adults with non-dialysis CKD. | Nadezhda Wall |
2019 | P421 | P421 -An unusual clinical presentation of Cryptococcal infection in a post renal transplant patient | Gayani Nadeesha Nishathi Wickrama Arachchi Appuhamilage |
2019 | P422 | P422 -Non-infective malakoplakia developing in a renal transplant and associated with poor outcome | Madelena Stauss |
2019 | P423 | P423 -Primary Renal Lymphoma: An Unusual Cause of Bilateral Nephromegaly | Khai Ping Ng |
2019 | P424 | P424 -Acquired C1-inhibitor deficiency presenting with nephrotic syndrome | Jamie Willows |
2019 | P425 | P425-Ruptured renal artery aneurysm leading to the diagnosis of Behçet´s disease | Astrid Baumann |
2019 | P426 | P426 -Malakoplakia in a renal transplant | Amrita Dhutia |
2019 | P427 | P427 -Iliohypogastric Nerve Injury Following Percutaneous Native Renal Biopsy | Anna Forbes |
2019 | P428 | P428 -A hidden cause of pulmonary oedema revealed by diagnostic persistence and teamwork. | Stephanie Urwin |
2019 | P429 | P429 -Burkholderia pseudomalei (meliodosis): An unusual cause of acute glomerulonephritis. | Andrew Fry |
2019 | P430 | P430 -A rare renal complication of ceftazidime therapy | Ashley Ferro |
2019 | P431 | P431 -Seronegativity in biopsy-proven lupus nephritis: 4 cases observed in white Caucasian men | Catherine Roberts |
2019 | P432 | P432 -Resistant hypertension secondary to bilateral renal artery stenosis: a case report | James Bannister |
2019 | P433 | P433 -Recurrent AKI with loin pain in a Caucasian competitive cyclist. Urate is part of the story. | Ashley Victoria Simpson |
2019 | P434 | P434 -Severe systemic toxicity following intra-sac methotrexate treatment of an ectopic caesarean scar pregnancy | Sarah Gleeson |
2019 | P435 | P435 -The nephrotoxic risks of online shopping | Lynn Zheng |
2019 | P436 | P436 -Rat bite fever: a case report | Rebecca Haggie |
2019 | P437 | P437 -Successful treatment of active lupus in a patient on haemodialysis using belimumab | Sarah Gleeson |
2019 | P438 | P438 -A young female with classical kidney biopsy appearances of anti-glomerular basement membrane disease in addition to thrombotic microangiopathy: a case report | Kashif Anwari |
2019 | P439 | P439 -Lessons from hyponatraemia management in a paediatric transplant recipient with extra-pontine myelinolysis and neurological sequelae. | Victoria Harkins |
2019 | P440 | P440 -Treatment of Glycogen Storage Disease Type 1a by combined Liver and Kidney Transplantation | Mukesh Kumar |
2019 | P441 | P441 -Darn if it's dry, darn if it's wet! | Muhammad Amaran |
2019 | P442 | P442 -The effect of dose, frequency and responsiveness on the dose conversion ratio for switching darbepoetin-alfa to PEG-epoetin beta: preserving haemoglobin control in non-haemodialysis patients with CKD | Owain Brooks |
2019 | P443 | P443 -The use of an adaptive student-centred approach to Renal Clinical skills teaching for medical students at a UK based district general hospital: a quality improvement project | Pratik Solanki |
2019 | P444 | P444 -Hospital specialty consultants working in primary care undertaking virtual reviews to improve identification and management of chronic kidney disease | Seema Singh |
2019 | P445 | P445 -Development of a nursing teaching program for general medical and surgical topics on a renal ward | Pratik Solanki |
2019 | P446 | P446 -Renal intra-professional education: A novel approach to up-skilling our renal trainees | Kathryn Watson |
2019 | P447 | Awareness and Attitude to Point of Care Creatinine Testing in a Tertiary Renal Unit | Danilo Nebres |
2019 | P448 | P448 -Benefits to the Nephrology MDT of Writing Outpatient Letters Directly to Patients | Ian Logan |
2019 | P449 | P449 -Tailoring consent discussions to account for the leading reasons for non-participation promotes recruitment to the SIMPLIFIED trial. | Norman Vincent Madeja |
2019 | P450 | P450-Renal trainees’ views on preparedness for consultant level work | Clare Castledine |
2019 | P451 | P451 - Clinical nurses’ understanding of the role of Clinical Research Nurse in the renal unit | Carlito Adan |
2019 | P452 | P452 -A pilot study to examine the perceived benefits of reflexology in patients undergoing hospital base haemodialysis - SOLITUDE | Michael Matthews |
2019 | P453 | P453 -Exploring the UK renal social worker role | Maaike Seekles |
2019 | P454 | P454 -Kidney Awareness Study Day | Sue Roberts |
2019 | P455 | P455 -Th17 Cells: A Source of a Pathogenic Circulating Factor? | Carl May |
2019 | P456 | P456 -Dapagliflozin may attenuate renal fibrosis by inhibition of novel Smad3 linker region phosphorylation | Xinlu Pan |
2019 | P457 | P457 -Proximal tubule damage is sustained in acute to chronic renal injury transition and specific early therapeutic intervention can limit the subsequent chronic kidney disease. | Ekramun Nabi |
2019 | P458 | P458 -Increased TACE and NLRP3 gene expression in chronic kidney disease (CKD) patients. | Sean Mc Callion |
2019 | P459 | P459 -Aristolochic acid and cisplatin differentially regulate retinoic acid activities in collecting duct cells and in kidneys of RARE-Luciferase mice | Qihe Xu |
2019 | P460 | P460 -Endogenous retinoic acid activity in collecting duct cells is a convergence point of regulation by AKI/CKD mediators | Qihe Xu |
2019 | P461 | P461 -Characterisation of Basal Myogenic Gene and Protein Expression in Skeletal Muscle of Advanced Chronic Kidney Disease Patients | Tom O'sullivan |
2019 | P462 | P462 -Using ultrasound scanning to investigate and treat a mouse model of obstructive uropathy | Natalie Milmoe |
2019 | P463 | P463 -Exploratory proteomics of urinary vesicles in chronic kidney disease progression | Elisabetta AM Verderio |
2019 | P464 | P464 -Kidney Patient Involvement Network (KPIN) | Paula Ormandy |
2019 | O82 | Reducing inpatient admissions by ambulating care for patients with acute kidney injury (AKI) | Nicholas Annear |
2019 | O325 | Myeloperoxidase inhibition: potential therapeutic target for crescentic glomerulonephritis? | Marilina Antonelou |
2019 | O253 | What mediates socioeconomic inequity in access to living-donor kidney transplantation? Results from a multicentre case-control study | Pippa Bailey |
2019 | O308 | IV iron dosing and infection risk in the PIVOTAL trial: a pre-specified secondary analysis | Sunil Bhandari |
2019 | O474 | Heart failure and AKI after hospital admission with AKI among patients taking ACE inhibitors and ARBs | Patrick Bidulka |
2019 | O367 | Proliferative glomerulonephritis with non-organised monoclonal immunoglobulin deposits (PGNMID): a single-centre retrospective study | Sarah Blakey |
2019 | O454 | Partnership working to provide bespoke renal welfare and debt management service | Jack Bramhall |
2019 | O541 | CYCLE-HD: Improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise. A randomised controlled trial. | James Burton |
2019 | O215 | Histological findings in acute interstitial nephritis – a role for scoring non-fibrotic inflammation. | Emma Cannon |
2019 | O423 | RNA regulation in renal disease: mutations in the ribonucleoproteins dyskerin and NOP10 are associated with a novel nephrotic syndrome | Jennie Chandler |
2019 | O124 | Natural history, outcomes and mortality associations of calciphylaxis: Update from the UK calciphylaxis registry | Rajkumar Chinnadurai |
2019 | O407 | Moving towards a risk based model for timing of pre-dialysis planning: our unit’s experience | Paul Cockwell |
2019 | O486 | Wide variance in transport provision for patients receiving in centre or satellite haemodialysis treatment in the UK: results of a national survey | Paul Cockwell |
2019 | O512 | Identification of high-risk patient clusters based on extracellular matrix turnover | Paul Cockwell |
2019 | O517 | The impact of utilising the Kidney Failure Risk Equation for referral into secondary care for individuals with chronic kidney disease in the UK | Paul Cockwell |
2019 | O398 | Development and implementation of MOVE: making exercise part of routine care for dialysis patients | Jennifer Cooney |
2019 | O453 | The effect of centre practice in initiating haemodialysis by an incremental approach compared to standard practice and short term patient survival | Andrew Davenport |
2019 | O241 | Adeno-Associated Virus Vector Gene Therapy Ameliorates Nephrosis in a Podocin-deficient Mouse Model of Nephrotic Syndrome | Wen Yi Ding |
2019 | O236 | Self-monitoring of Urine Specific Gravity using Study Smartphone Applications Promotes Adherence to High Water therapy and facilitates remote data capture in the DRINK Randomised Trial | Ragada El-damanawi |
2019 | O389 | Chorioretinal thickness tracks disease activity in clinical ANCA vasculitis | Tariq Farrah |
2019 | O478 | Association between non-malignant monoclonal gammopathy and risk of adverse outcomes in chronic kidney disease | Anthony Fenton |
2019 | O525 | Correlation between kidney sizes and split renal function in prospective living kidney donors | Anthony Fenton |
2019 | O316 | How common is contrast induced acute kidney injury (CI-AKI) in patients undergoing coronary angiography and percutaneous coronary intervention (PCI)? | Amy Forrester |
2019 | O442 | The Kidney Quality Improvement Partnership (KQuIP): Developing and embedding Quality Improvement capability within the kidney community – a local, regional, and national approach | Rachel Gair |
2019 | O156 | A novel heparanase inhibitor protects glomerular endothelial glycocalyx during diabetes mellitus | Monica Gamez |
2019 | O368 | Prophylactic eculizumab treatment significantly improves renal allograft survival in patients with atypical haemolytic uremic syndrome compared with historic controls | Emily Glover |
2019 | O117 | Innate immune response biomarkers in peritoneal dialysis effluent as reliable diagnostic indicators of peritonitis - evaluation of a rapid diagnostic test device | Cate Goodlad |
2019 | O85 | The effect of initiation of renin-angiotensin system inhibitors on haemoglobin | George Greenhall |
2019 | O545 | A study of Factors AssoCiated with Treatment Resistant HYpertension (FACT-RHY): a description of phenotypical, physiological and biochemical characteristics of patients with true treatment-resistant hypertension compared to treated patients with hypertension. | Mohammed Hameed |
2019 | O415 | The functional consequences of myocardial fibrosis in chronic kidney disease | Manvir Kaur Hayer |
2019 | O67 | Outcomes in the first 90 days after starting dialysis – transition of the UK Renal Registry to capture of all acute and chronic dialysis sessions | Barny Hole |
2019 | O108 | Temporal trends in prevalence of chronic kidney disease in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016 | Hilda Hounkpatin |
2019 | O319 | Lessons learned from the development and evaluation of a virtual renal clinic. | Sally Hull |
2019 | O381 | Increasing the prevalence of shared haemodialysis care at Salford Royal Foundation Trust dialysis units | Emma Jenner |
2019 | O522 | HLA antibody and Tacrolimus variability in transplant recipients during transition from paediatrics to regional adult units. | Shilpa Kaki |
2019 | O113 | Acute Kidney Disease - a new definition, but is it useful in describing renal outcomes following AKI? | Isma Kazmi |
2019 | O134 | Long Term Effects of Acute Kidney Injury on Chronic Kidney Disease and Patient Outcomes: 3-year Results from a Large Prospective Parallel Group Cohort Study | Isma Kazmi |
2019 | O370 | Do clinical staff activate patients? The relationship between Clinician Support for Patient Activation and the Patient Activation Measure in In-centre haemodialysis patients. | Maria Keriakos |
2019 | O167 | Comparing active lifestyle intervention using renal dietician-led behaviour change techniques versus standard of care after kidney transplantation (CAVIAR): a randomised controlled trial. | Kulli Kuningas |
2019 | O270 | A novel small molecule therapy rescues trafficking of misfolded podocin and corrects Nephrotic Syndrome caused by a common podocin mutation | Valeryia Kuzmuk |
2019 | O528 | An Unusual Infiltrative Cause of Acute-on-Chronic Kidney Injury | Hugh Leonard |
2019 | O76 | Physical activity and exercise behaviours of peritoneal dialysis patients in England: results from a multi-centre observational trial | Courtney Lightfoot |
2019 | O445 | Using three-dimensional imaging to study how kidney lymphatic vessels develop | David Long |
2019 | O494 | Standards for Transport Provision for Patients receiving in centre or satellite unit haemodialysis: Finding a Way Together | Fiona Loud |
2019 | O50 | Barriers to kidney transplantation in children – ATTOMic prospective national study | Stephen Marks |
2019 | O229 | Analysis of intensified immunosuppression response in genetically-stratified steroid resistant nephrotic syndrome (SRNS) patients predicts outcomes and suggests distinct immune mechanisms | Anna Mason |
2019 | O242 | Signalling Response Under Par: A PAR-1 mediated signalling pathway in podocytes is a consistent feature of ‘circulating factor’ initiated nephrotic syndrome. | Carl May |
2019 | O495 | Fostamatinib treatment of a new model of MPO-ANCA vasculitis in WKY rats induced by administration of a sub-nephritogenic dose of nephrotoxic serum after immunisation with human myeloperoxidase | Stephen Mcadoo |
2019 | O497 | Long-term follow up of a steroid-minimising regimen for remission-induction in ANCA associated vasculitis | Stephen Mcadoo |
2019 | O439 | A paediatric AKI service: Improving recognition and reducing incidence | Grace Mccall |
2019 | O334 | MinTac: A prospective, multicentre, randomised controlled trial of tacrolimus vs prednisolone for adults with de novo minimal change disease. | Nicholas Medjeral-Thomas |
2019 | O87 | Inspiring a generation: A Renal Taster Weekend for prospective nephrologists | Anjali Menon |
2019 | O388 | The Electronic Frailty Index (eFI) Indicates Mortality Risk in End Stage Kidney Disease (ESKD) Patients on Dialysis | Andrew Mooney |
2019 | O158 | Donor gender and recipient outcomes after kidney transplantation: a population cohort analysis from the United Kingdom | Georgia Morgan |
2019 | O30 | Healthcare related activity following kidney transplantation. | Eleanor Murray |
2019 | O341 | Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis – A randomised controlled trial. | Lina Nikolopoulou |
2019 | O21 | Developing an in situ simulation programme on renal emergencies to facilitate improvement in multidisciplinary working | Ailish Nimmo |
2019 | O212 | Prognostic accuracy of frailty screening methods in advanced chronic kidney disease | Andrew Nixon |
2019 | O329 | Longitudinal effects of depression on cognitive function in haemodialysis patients | Aghogho Odudu |
2019 | O240 | Characterisation of senescent renal epithelial cells in experimental renal disease reveals transcriptional heterogeneity at a single cell level | Eoin O'Sullivan |
2019 | O94 | Diabetes during pregnancy and congenital genitourinary malformations: A systematic review and meta-analysis | Mounika Parimi |
2019 | O267 | Feasibility of non-contrast cardiac MR stress T1-mapping to assess coronary artery disease in patients on haemodialysis | Federica Poli |
2019 | O446 | A novel P2X7 knockout rat is not protected from experimental glomerulonephritis or vasculitis | Maria Prendecki |
2019 | O449 | The effect of P2X7 antagonism on nephrotoxic nephritis | Maria Prendecki |
2019 | O286 | Renal Outcome in Patients with Newly Diagnosed Multiple Myeloma: Results from the UK NCRI Myeloma XI trial. | Ritika Rana |
2019 | O484 | A Study Of Maternal and Fetal Outcomes in a Cohort of Pregnant Women with Chronic Kidney Disease | Nadia Sarween |
2019 | O248 | A model of cardiovascular disease in people with reduced renal function using routine healthcare data | Claire Simons |
2019 | O18 | Poor advance care planning in older patients with end-stage renal disease: a qualitative interview study of nephrologists. | Andrew Smyth |
2019 | O375 | CKD-PAQ: Developing a tool for physical activity estimation in chronic kidney disease | Sivakumar Sridharan |
2019 | O79 | Focal segmental necrotising glomerulonephritis associated with selective IgA deficiency: two case reports | Madelena Stauss |
2019 | O378 | The Impact of Acute Kidney Injury Requiring Haemodialysis on Patient Survival: 10 years of Prospective Data - An Australian Perspective | Benjamin Talbot |
2019 | O520 | Introducing a tool to implement Transplant First: Identifying barriers to transplant listing, measuring for improvement, and lessons learned from a pilot centre. | Kerry Tomlinson |
2019 | O536 | Comparative effects of oral anti-diabetic agents after metformin monotherapy in UK primary care: a propensity-score matched cohort study | Laurie Tomlinson |
2019 | O359 | Live glomerular imaging in experimental crescentic glomerulonephritis reveals sequential glomerular infiltration of monocyte subsets with distinct effector functions | Tabitha Turner-Stokes |
2019 | O518 | Acceptability of alternate day dialysis regimes to patients on in-centre maintenance dialysis: a multi-centre survey | Enric Vilar |
2019 | O12 | Skin autofluorescence and malnutrition as predictors of mortality in dialysis patients. | Daniela Viramontes Horner |
2019 | O25 | Clinical and biochemical characteristics of hypokalaemic patients: predictors of a genetic diagnosis of Gitelman or Bartter syndrome | Elizabeth Wan |
2019 | O31 | 24-hour versus spot urinary sodium and potassium measurements in adult hypertensive patients: a cohort validation study | Elizabeth Wan |
2019 | O129 | Conception intentions and pregnancy experiences amongst women of childbearing age on dialysis | Philip Webster |
2019 | O244 | A programme of supervised exercise and multidisciplinary education (PREHAB) prevents deterioration in physical function and nutritional status in persons approaching and commencing dialysis | Fiona Willingham |
2019 | O417 | What information do staff use to involve patients in decisions about conservative management? A critical review of leaflets used in UK renal services. | Anna Winterbottom |